| Name | Title | Contact Details |
|---|
WAVE Life Sciences is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering exceptional treatment options for patients. Given the unique versatility of its chemistry platform, WAVE`s pipeline will span multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded RNAi.
Washington Regional Transplant Consortium is a Annandale, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
IOS Foundation is a Chagrin Falls, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Neuroplasticity targeting electrical fields delivered by a wearable interface, to help the brain regain control of immune function
Intelligent InSites, Inc. is a leading provider of automation solutions that transform healthcare.